Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.21.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Jul. 03, 2021
Jun. 28, 2020
Jul. 03, 2021
Jun. 28, 2020
Net sales $ 118,666 $ 71,801 $ 322,015 $ 264,351
Cost of goods sold 88,427 68,819 246,677 220,893
Gross profit 30,239 2,982 75,338 43,458
Selling, general and administrative expenses 19,914 15,206 53,005 51,130
Other (income) loss, net (1,578) 9,364 (218) 7,724
Operating income (loss) 11,903 (21,588) 22,551 (15,396)
Interest expense, net 1,735 1,710 5,225 5,320
Earnings before provision for (benefit from) income taxes 10,168 (23,298) 17,326 (20,716)
Provision for (benefit from) income taxes 2,019 (5,454) 4,032 (4,884)
Consolidated net earnings (loss) 8,149 (17,844) 13,294 (15,832)
Net loss attributable to non-controlling interest 12 63 149 286
Net earnings (loss) attributable to shareholders $ 8,161 $ (17,781) $ 13,443 $ (15,546)
Basic earnings (loss) per share (in dollars per share) $ 1.17 $ (2.58) $ 1.93 $ (2.24)
Diluted earnings (loss) per share (in dollars per share) $ 1.14 $ (2.58) $ 1.90 $ (2.24)
Weighted average number of shares outstanding (in shares) 6,975 6,890 6,956 6,932
Dilutive effect of stock awards (in shares) 153 0 121 0
Weighted average number of shares assuming dilution (in shares) 7,128 6,890 7,077 6,932